Pulmatrix Statistics
Total Valuation
Pulmatrix has a market cap or net worth of $32.80 million. The enterprise value is $25.09 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, before market open.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Pulmatrix has 3.65 million shares outstanding.
| Current Share Class | 3.65M |
| Shares Outstanding | 3.65M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.66% |
| Owned by Institutions (%) | 8.62% |
| Float | 3.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 17.07 |
| Forward PS | n/a |
| PB Ratio | 4.59 |
| P/TBV Ratio | 4.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.90
| Current Ratio | 8.90 |
| Quick Ratio | 8.55 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -93.19% and return on invested capital (ROIC) is -35.01%.
| Return on Equity (ROE) | -93.19% |
| Return on Assets (ROA) | -31.67% |
| Return on Invested Capital (ROIC) | -35.01% |
| Return on Capital Employed (ROCE) | -136.25% |
| Revenue Per Employee | $960,500 |
| Profits Per Employee | -$6.10M |
| Employee Count | 2 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +378.42% in the last 52 weeks. The beta is 1.38, so Pulmatrix's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | +378.42% |
| 50-Day Moving Average | 6.49 |
| 200-Day Moving Average | 5.22 |
| Relative Strength Index (RSI) | 69.60 |
| Average Volume (20 Days) | 20,560 |
Short Selling Information
The latest short interest is 18,153, so 0.50% of the outstanding shares have been sold short.
| Short Interest | 18,153 |
| Short Previous Month | 23,827 |
| Short % of Shares Out | 0.50% |
| Short % of Float | 0.50% |
| Short Ratio (days to cover) | 1.51 |
Income Statement
In the last 12 months, Pulmatrix had revenue of $1.92 million and -$12.19 million in losses. Loss per share was -$3.34.
| Revenue | 1.92M |
| Gross Profit | 1.89M |
| Operating Income | -9.74M |
| Pretax Income | -8.85M |
| Net Income | -12.19M |
| EBITDA | -9.67M |
| EBIT | -9.74M |
| Loss Per Share | -$3.34 |
Full Income StatementBalance Sheet
The company has $7.71 million in cash and n/a in debt, giving a net cash position of $7.71 million or $2.11 per share.
| Cash & Cash Equivalents | 7.71M |
| Total Debt | n/a |
| Net Cash | 7.71M |
| Net Cash Per Share | $2.11 |
| Equity (Book Value) | 7.15M |
| Book Value Per Share | 1.96 |
| Working Capital | 7.14M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.81 million and capital expenditures -$244,000, giving a free cash flow of -$10.05 million.
| Operating Cash Flow | -9.81M |
| Capital Expenditures | -244,000 |
| Free Cash Flow | -10.05M |
| FCF Per Share | -$2.75 |
Full Cash Flow StatementMargins
| Gross Margin | 98.28% |
| Operating Margin | -506.98% |
| Pretax Margin | -634.67% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |